![]() |
市場調查報告書
商品編碼
1305940
醫用級有機矽市場規模 - 按形態(凝膠、橡膠、泡沫、片材、塊狀)、按應用(呼吸設備、醫療器械部件、植入物、骨科器械) - 全球預測(2023-2032年)Medical Grade Silicone Market Size - By Form (Gel, Rubber, Foam, Sheet, Block), By Application (Respiratory Devices, Medical Device Components, Implants, Orthopedic Forms)- Global Forecast (2023-2032) |
到2032年,全球醫用級有機矽市場規模將大幅擴大。癌症、心臟病、糖尿病等慢性疾病的發病率不斷上升,增加了對醫療器械的需求,提高了對醫用級有機矽的需求。根據紐約州衛生部的資料,美國每年約有697,000人死於心臟病,每5人中就有1人死於心臟病。
此外,人們對醫用級矽膠益處的認知不斷提高,也將進一步促進該行業的發展。醫用級矽膠的生物相容性、柔韌性、柔軟性、耐用性和易消毒性使其成為廣泛的醫療應用領域的重要材料。從植入物和假體到傷口敷料和醫用管材,有機矽有助於提高患者的舒適度、安全性和治療效果,促進行業成長。
整個醫用級有機矽市場根據形態、應用和地區進行分類。
根據形態,凝膠細分市場的行業佔有率將在2023年至2032年期間以超過7%的年複合成長率成長。有機矽凝膠以其耐用性和使用壽命長而著稱。它們具有抗分解性,可在較長時間內保持其物理性質。這種耐久性使其適合長期用於醫療設備、植入物或需要持續性能和可靠性的外部應用。此外,從用於假肢和植入物的非常柔軟的凝膠到用於傷口治療的非常粘稠的凝膠等各種質地的凝膠的高可用性也有利於其應用。
就應用領域而言,到2032年,骨科產品領域的行業價值將呈指數級成長。骨科疾病(如退行性骨病)發病率的不斷成長提高了產品的採用率。根據美國疾病預防控制中心(CDC)的資料,僅在美國,約有4.2%的50歲及以上男性和18.8%的50歲及以上女性患有腰椎或股骨頸骨質疏鬆症。此外,骨科設備投資的增加也將進一步促進該細分市場的成長。
到2032年,歐洲醫用級有機矽市場規模將超過7.5億美元。該地區擁有Wacker Chemie AG等主要市場參與者,都重視產品創新。此外,心臟病、癌症等慢性疾病發病率的上升也增加了該地區對醫療器械的需求,刺激了對醫用級有機矽的需求。
Global Medical Grade Silicone Market size will expand significantly through 2032. Surging prevalence of chronic disorders such as cancer, heart attack, diabetes, and others has increased the need for medical devices, increasing the demand for medical grade silicone. According to the New York State Department of Health, heart diseases claim around 697,000 lives in the U.S. every year, accounting for one in every five deaths.
Moreover, rising awareness of the benefits of medical grade silicone could further contribute to industry growth. Medical-grade silicone's biocompatibility, flexibility, softness, durability, and ease of sterilization make it a valuable material in a wide range of medical applications. From implants and prosthetics to wound dressings and medical tubing, silicone contributes to improved patient comfort, safety, and treatment outcomes, leading to industry growth.
The overall medical grade silicone market is categorized based on form, application, and region.
Based on form, industry share from gel segment will grow at over 7% CAGR from 2023 to 2032. Silicone gels are known for their durability and longevity. They are resistant to degradation and can maintain their physical properties over an extended period. This durability makes them suitable for long-term use in medical devices, implants, or external applications that require sustained performance and reliability. Moreover, high availability of these gels in various textures, from very soft gels used in prosthetics and implants to very sticky gels used in wound treatment, favors their adoption.
In terms of application, the industry value from the orthopedic products segment will amass exponential gains through 2032. Growing incidence of orthopedic disorders such as degenerative bone disease has increased product adoption. As per the CDC, around 4.2% of men and 18.8% of women 50 years of age and over suffer from osteoporosis of the lumbar spine or femur neck in the U.S. alone. Moreover, rising investments in orthopedic equipment will further supplement segment growth.
Europe medical grade silicone market size will be worth over USD 750 million by 2032. The region is home to major market players such as Wacker Chemie AG and others emphasizing product innovations. Moreover, the rising prevalence of chronic disorders such as heart disease, cancer, and others has increased the need for medical devices in the region, stimulating the demand for medical grade silicone.